
GEHC Stock Forecast & Price Target
GEHC Analyst Ratings
Bulls say
GE HealthCare Techs is a global leader in the medical technology industry, with a diverse portfolio of products and solutions. Its strong focus on innovation and strategic growth initiatives, such as acquisitions and R&D investments, position the company for future success. Additionally, GEHC's commitment to increasing margins and driving recurring revenue through services and pharmaceutical products bodes well for its financial outlook. While competition and regulatory compliance remain challenges, the company is actively addressing these issues and has a positive long-term outlook.
Bears say
GE HealthCare Techs is heavily reliant on their imaging segment, which accounts for almost half of their revenue, while other important segments, such as advanced visualization solutions and patient care solutions, only account for around 40%. Additionally, the company's reliance on the US market leaves them vulnerable to any changes in healthcare policies, and their recurring revenue only makes up about half of their total revenue, which could impact their stability and growth potential in the future. Furthermore, with potential risks related to manufacturing, supply chain, and regulatory issues, there are significant uncertainties surrounding the company's ability to maintain its current market position and continue to innovate and compete in the highly competitive medical technology industry.
This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
GEHC Analyst Forecast & Price Prediction
Start investing in GEHC
Order type
Buy in
Order amount
Est. shares
0 shares